Objectives This study aimed to analyse depression and anxiety symptoms changes from the first to the third trimester of pregnancy in non-smokers versus quitters versus continuous smokers, and the contribution of depression and anxiety symptoms to continued tobacco consumption during pregnancy. Methods The sample comprises 850 Spanish pregnant women (595 non-smokers, 123 quitters, and 132 continuous smokers), assessed at the first and the third trimester of pregnancy with a questionnaire concerning socio-demographic, obstetric, and tobacco consumption information, and measures of depression and anxiety. Results Continuous smokers during pregnancy showed more depression and anxiety symptoms than both non-smokers and quitters and no changes from the first trimester to the third trimester of pregnancy, while both non-smokers and quitters revealed a decrease in depression and anxiety symptoms. More anxiety symptoms at the first trimester (OR 1.03) and depression symptoms at the third trimester (OR 1.14) were associated with continued smoking during pregnancy. Conclusions Anxiety and depression symptoms need to be considered to screening for women at risk of smoking during pregnancy. Future prenatal smoking cessation interventions must take into account these variables.
Introduction
Tobacco consumption during pregnancy is one of the main factors associated with adverse health outcomes for women and their children (USDHHS 2014) . Although some women spontaneously quit smoking after knowing that they are pregnant (Schneider et al. 2010) , other pregnant women continue smoking even knowing the risk involved.
Previous studies on tobacco consumption during pregnancy have compared smokers with quitters characteristics (e.g. Coleman-Cowger et al. 2013; Erlingdottir et al. 2014; Goedhart et al. 2009) or smokers with non-smokers (Al-Sahab et al. 2010; Giglia et al. 2007; Orr et al. 2012) . Including women who have never smoked and those who quit smoking during pregnancy in the same non-smokers group (e.g. Al-Sahab et al. 2010; Orr et al. 2012 ) may provide underrepresented data as different consumption profiles and associated factors are considered as the same one. However, knowing about the differences between smokers and quitters may provide relevant information, namely regarding why some smokers quit and others continue smoking during pregnancy. On the other hand, exploring the differences among the three groups-nonsmokers, quitters, and continuous smokers across pregnancy-may also add relevant information to the field of tobacco consumption, mainly regarding the benefits of quitting smoking during pregnancy.
More information on the main aspects associated with continuing smoking throughout pregnancy is needed to target relevant causes and to offer the necessary specific support to quit smoking during pregnancy. Research on this subject lacks a longitudinal and prospective approach with biochemical test of smoking abstinence, as data may be biased by women's memory and/or by social desirability due to social pressure on quitting smoking (Míguez and Pereira 2018) . Studies have been based mostly on nonconfirmed information of abstinence from retrospective self-reports (e.g. Dupraz et al. 2013) or cross-sectional surveys focusing on abstinence in one specific moment of pregnancy (Erlingdottir et al. 2014; Giglia et al. 2007; Goedhart et al. 2009 ). Cross-sectional studies show partial results because they do not assess changes in major variables that could differently affect consumption depending on the period of gestation evaluated. Therefore, it is necessary to use a robust methodology that allows the obtention of more precise data.
Smoking during pregnancy has been associated with several socio-demographic risk factors, such as a young age and low educational level (Balwicki et al. 2016; Krstev et al. 2012; Orton et al. 2014) , low economic level (Balwicki et al. 2016; Krstev et al. 2012; Maxson et al. 2012) , unemployment (Balwicki et al. 2016; Orton et al. 2014; Smedberg et al. 2014) , unexpected pregnancy (Suzuki et al. 2010) , and having a smoking partner (Orr et al. 2012 ). On the other hand, women intending to breastfeed were found to be less likely to smoke during pregnancy (Haslam et al. 2003) . Smoking during pregnancy has also been associated with depression and/or anxiety symptoms, but results are somewhat controversial. The majority (Linares-Scott et al. 2009; Maxson et al. 2012; Smedberg et al. 2014; Tong et al. 2016) , but not all (Beijers et al. 2014; Blaga et al. 2017; Meghea et al. 2010) , studies have linked smoking with the presence of depression or depression symptoms. Moreover, although the relationship between anxiety and smoking in pregnancy has been less investigated, some studies suggest that smoking during pregnancy is more prevalent in women with higher levels of anxiety (Blaga et al. 2017; Goedhart et al. 2009; Tong et al. 2016 ), while others have not found this association (e.g. Beijers et al. 2014; Massey and Compton 2013) .
Pregnancy is a stage of critical psychological vulnerability for women. Tobacco consumption and psychological adjustment problems during pregnancy are strongly associated and have a similar adverse impact on the infant health and development. For example, maternal depression during pregnancy was found to increase the risk of prematurity, low birthweight, and later emotional and behavioural problems (see Field 2011) . Depression and anxiety symptoms were associated with tobacco consumption, and tobacco consumption was found to affect depression and anxiety symptoms (Taylor et al. 2014 ). However, the interaction between these two aspects need to be better explored, mainly at different times of pregnancy, because it is unclear whether these depressive and anxious symptoms are influenced by tobacco consumption depending on the trimester of pregnancy. Many smokers think that smoking offers mental health benefits; however, some studies show the opposite, that is, an association between smoking cessation and a decrease in depression, anxiety, and stress, as well as an improvement in mood and quality of life (Taylor et al. 2014) . To explore the influence of continuing or quitting smoking during pregnancy on women's depression and anxiety symptoms over pregnancy is relevant for clinical practice and research.
This study aimed to analyse: (1) anxiety and depression symptoms changes from the first to the third trimester of pregnancy in non-smokers versus quitters versus continuous smokers and (2) the contribution of anxiety and depression symptoms to continued tobacco consumption in women from the first to the third trimester of pregnancy.
Methods

Participants
A total of 915 pregnant women were invited to participate in the study, 11 declined to participate and three could not be enrolled, as they were not proficient in Spanish. From the 901 women who accepted to participate and were assessed at the first trimester, 28 had suffered a miscarriage, 14 could not be contacted, and two declined to participate at the third trimester of pregnancy. From 857 (95.1%) women assessed at the third trimester of pregnancy, seven reported having quit smoking after the first trimester of pregnancy and were excluded from the analyses. Therefore, the sample of this study was comprised of 850 pregnant women assessed at the first (M = 9.93 gestational weeks; SD = 4.19; age range 4-20 weeks) and third (M = 33.28 gestational weeks; SD = 2.04; age range 26-40) trimester of pregnancy. Participants' age ranged between 18 and 46 years old (M = 32.72 years; SD = 4.35). Most participants were married or cohabiting (83.3%). More than half were over 30 years old (72.0%), were employed at the first trimester of pregnancy (71.2%), were primiparous (66.4%), had university studies (53.1%), and had a maximum household income of 2000 euros net per month (57.4%).
More than half of pregnant women had never smoked or had given up smoking before pregnancy (70.0%; n = 595), while 14.5% (n = 123) spontaneously quitted at the first pregnancy trimester and 15.5% (n = 132) continued smoking during pregnancy.
Procedure
The present research was conducted in accordance with the Declaration of Helsinki and received previous approval from the ethical commission of all institutions involved.
Pregnant women attending a primary health public care service in Northwest Spain (December 2012-September 2014) were recruited through consecutive probabilistic sampling at the first trimester of pregnancy. The number of births in the year preceding the study according to official data was used to calculate the sample size and to insure representativeness with a confidence level of 95% and an accuracy of 3.4%. The aims and procedures were explained, and pregnant women who were willing to participate provided a written informed consent. Following, two trained psychologists carried out the interviews individually. This is a observational prospective longitudinal study with two assessment waves, at the first and the third trimester of pregnancy. Women were assessed at both assessment waves with an ad hoc questionnaire on sociodemographic, obstetric, and tobacco consumption information, and measures of depression and anxiety symptoms. The average time for assessment of each participant in each trimester was 20 min. At the third trimester, an appointment was performed by telephone to schedule the interview. Pregnant women choose the day, time, and place of the interview. Most women (80.0%) preferred to perform this assessment in their homes.
To avoid potential biases in the classification of women in their consumption group, biochemical tests (cotinine concentration in urine at the first trimester of pregnancy and carbon monoxide in expired air at the third trimester of pregnancy) were performed to confirm the self-reported consumption status. Likewise, in regression analysis, the socio-demographic and obstetric variables that differentiated the consumption groups (confounding variables) were controlled.
Pregnant women were classified into three groups based on their self-report tobacco consumption and the results of the biochemical test: (1) non-smokers-non-smoking before (or since long time before) pregnancy and throughout pregnancy; (2) quitters-quitting smoking at the first trimester of pregnancy (when pregnancy suspected/confirmed) and non-smoking throughout pregnancy;
(3) continuous smokers-maintained tobacco consumption throughout pregnancy.
Measures
Socio-demographic and tobacco consumption information
Information regarding socio-demographic characteristics (e.g. age, marital and occupational status, parity, education, and monthly household income), psychopathology diagnosed, pregnancy-related variables (e.g. number of gestational weeks, planned pregnancy, and breastfeeding intention) and consumption information (e.g. smoking status and having a partner who smokes) was obtained for this study.
Self-reports of smoking abstinence were biochemically verified through urinary cotinine by Cotinine Test Medimarketing (cut-off 200 ng/mL) at the first trimester and through the evaluation of expired air carbon monoxide (CO) at the third trimester (cut-off of 5 ppm) using a carbon monoxide monitor (Model Smokerlyzer Pico Simple; Bedfont Technical Instruments Ltd., Sittingbourne, Kent, UK). Biochemical measurement and self-report were combined to establish smoking status.
Edinburgh Postnatal Depression Scale (EPDS; Cox et al. 1987) EPDS is a 10-item self-reported questionnaire designed to assess the intensity of depression symptoms within the previous 7 days. Higher scores indicate more intensity of depression symptoms. It is the most widely used questionnaire for detection of postpartum depressive symptoms, although it has also been validated to detect depression during pregnancy. In the Spanish validation (Vázquez and Míguez 2019), the recommended cut-off score is 10. In the present study, the EPDS showed good internal consistency (Cronbach's a = 0.85 at the first trimester of pregnancy and 0.77 at the third trimester of pregnancy).
State Anxiety Scale of State-Trait Anxiety Inventory (STAI; Spielberger et al. 1970; Spanish version TEA, 1982) The STAI-S consists of 20-item self-reported scale designed to assess the current state of anxiety. Higher scores indicate higher anxiety symptoms. The STAI-S Spanish version proposed a clinical cut-off of 32 (75th percentile) to screen for high anxiety in women. In the present study, the STAI-S showed excellent internal consistency (Cronbach's a = 0.94 at the first trimester of pregnancy and 0.91 at the third trimester).
Data analysis
Preliminary analyses were performed using Chi-square tests to analyse the characteristics (socio-demographic, obstetric, and psychological) of smoking status groups (non-smokers, quitters, continuous smokers). A repeatedmeasures multivariate analysis of variance (MANOVA) was performed to analyse anxiety and depression symptoms changes from the first to the third trimester of pregnancy in non-smokers versus quitters versus continuous smokers. The model included smoking status groups as the between-subjects factor and women's depression and anxiety symptoms as within-subjects' factors with two levels: EPDS and STAI-S scores at the first and the third trimester of pregnancy. A MANOVA was performed to explore differences between the smoking status groups on women's depression and anxiety symptoms at the first and the third trimester of pregnancy. The model included smoking status groups as the independent variable and women's depression and anxiety symptoms (at the first and the third trimester of pregnancy) as dependent variables. Pairwise comparisons were applied to assess within and between group differences.
A three-step logistic regression was performed to analyse anxiety and depression symptoms associated with continued tobacco consumption in women from the first to the third trimester of pregnancy. The first step (enter method) was performed to control confounding variables associated with the smoking status groups (specifically, marital status, education, monthly household income, parity, smoking partner, pregnancy influenced work, planned pregnancy, breastfeeding intention, and previous psychopathology diagnosed). The second and third steps were made to know which psychological variables predicted consumption status, specifically anxiety and depression symptoms at the first and third trimester of pregnancy. The second step (stepwise method) was performed to clarify whether the strongest predictor of continued tobacco consumption in women during pregnancy is anxiety or depression symptoms at the first trimester of pregnancy. The third step (stepwise method) was performed to clarify whether there are anxiety or depression symptoms at the third trimester of pregnancy that are associated with continued tobacco consumption in women during pregnancy (adjusting the model for anxiety and depression symptoms at the first trimester of pregnancy). All the three steps included continued tobacco consumption during pregnancy as dependent variable.
Cramer's V coefficients and partial eta-squared (gp 2 ) were calculated to estimate the effect size. Data were analysed with IBM SPSS 23.0 version (SPSS Inc, Chicago).
Results
Preliminary analyses: associations between smoking status and socio-demographic, obstetric, and psychological variables Significant associations were found between smoking status and socio-demographic, obstetric, and psychological characteristics (see Table 1 ). Regarding socio-demographic characteristics, non-smokers are more likely to be married or living with partner than continuous smokers during pregnancy, to be higher educated, less likely to receive a monthly salary lower than 2000€, more likely to live with a non-smoking partner than quitters or continuous smokers, and less likely to be multiparous than quitters. Quitters are more likely to be higher educated and less likely to live with a non-smoking partner than continuous smokers during pregnancy. Regarding obstetric characteristics, non-smokers are more likely to report that pregnancy did not influence their work than quitters or continuous smokers during pregnancy, and more likely to report that pregnancy was desired and that they intended to breastfeed their infant than continuous smokers. Regarding psychological characteristics, non-smokers are less likely to present previous psychopathology than continuous smokers, less likely to be depressed or anxious at the first trimester of pregnancy than quitters or continuous smokers, and less likely to be depressed or anxious at the third trimester of pregnancy than continuous smokers during pregnancy.
Differences on women's depression and anxiety from the first to the third trimester of pregnancy, according to smoking status
The repeated-measures MANOVA revealed significant multivariate (Wilk's Lambda = 0.98, F 2,846 = 6.87, p = 0.001, gp 2 = 0.02) and univariate time effects on women's depression and anxiety symptoms. Women's depression and anxiety symptoms decreased from the first to the third trimester of pregnancy. No significant effects of the interaction between time and smoking status were found on women's depression and anxiety. However, pairwise comparisons noted that non-smokers and quitters revealed a significant decrease on depression and anxiety symptoms, while continuous smokers during pregnancy revealed no significant changes on depression and anxiety symptoms from the first to the third trimester of pregnancy (see Table 2 and Fig. 1A, B ).
The MANOVA results were statistically significant. The univariate results revealed significant effects of smoking status on women's depression (F 2,847 = 14.98, p \ 0.001, gp 2 = 0.03) and anxiety symptoms (F 2,847 = 14.49, p \ 0.001, gp 2 = 0.03) at the first trimester of pregnancy and on women's depression (F 2,847 = 16.88, p \ 0.001, gp 2 = 0.04) and anxiety symptoms (F 2,847 = 14.56, p \ 0.001, gp 2 = 0.03) at the third trimester of pregnancy. Pairwise comparisons revealed that continuous smokers during pregnancy showed more depression and anxiety symptoms at the first and at the third trimester of pregnancy than non-smokers and quitters. No differences were found between non-smokers and quitters on depression and anxiety symptoms at the first and the third trimester of pregnancy. Depression and anxiety symptoms associated with continued tobacco consumption in women from the first to the third trimester of pregnancy
The first step regression was statistically significant (v 7 2 = 23.32, p = 0.006). The model explained 10-14% of the variance in continued tobacco consumption (Cox and Snell R 2 = 0.10, Nagelkerke R 2 = 0.14) and correctly classified 66.4% of cases. Women without a college degree (OR = 2.46) and with smoker partner (OR = 2.27) were more likely to continue smoking during pregnancy. Pairwise comparisons applied to non-smokers group: depression symptoms, p = 0.015, anxiety symptoms, p = 0.003 2 Pairwise comparisons applied to quitters group: depression symptoms, p = 0.035, anxiety symptoms, p = 0.045 3 Pairwise comparisons applied to smokers group: depression symptoms, p = 0.117, anxiety symptoms, p = 0.127 I 1 versus 2, p = 0.130; 1 versus 3, p \ 0.001; 2 versus 3, p = 0.036 II 1 versus 2, p = 0.814; 1 versus 3, p \ 0.001; 2 versus 3, p = 0.001 III 1 versus 2, p = 0.190; 1 versus 3, p \ 0.001; 2 versus 3, p = 0.028 IV 1 versus 2, p = 0.816; 1 versus 3, p \ 0.001; 2 versus 3, p = 0.003 ***p \ 0.001
The second step regression was statistically significant (v 10 2 = 29.63, p = 0.001). The model explained 13-17% of the variance in continued tobacco consumption (Cox and Snell R 2 = 0.13, Nagelkerke R 2 = 0.17) and correctly classified 67.3% of cases. More anxiety symptoms at the first trimester (OR = 1.03) increased the probability of continued smoking during pregnancy.
The third step regression was statistically significant (v 10 2 = 38.64, p = 0.001). The model explained 17-22% of the variance in continued tobacco consumption (Cox and Snell R 2 = 0.17, Nagelkerke R 2 = 0.22) and correctly classified 67.3% of cases. More depression symptoms at the third trimester (OR = 1.14) were associated with continued smoking during pregnancy (see Table 3 ).
Discussion
Depression and anxiety symptoms trajectories from the first to the third trimester of pregnancy were in the present study similar to the ones found in the literature, that is a decrease in anxiety and depression symptoms from the first to the third trimester of pregnancy (e.g. Andersson et al. 2006; Figueiredo and Conde 2011) . Interestingly, depression and anxiety symptoms changes from the first to the third trimester of pregnancy are different in non-smokers versus quitters versus continuous smokers during pregnancy, with continuous smokers not exhibiting the normative decrease in depression and anxiety symptoms across pregnancy, as found in quitters and non-smokers. Moreover, anxiety symptoms at the first trimester were associated with continued smoking during pregnancy. Additionally, continued smoking during pregnancy was associated with more depression symptoms at the third trimester. These results clarify how anxiety and depression symptoms are related to continued smoking during pregnancy.
Several socio-demographic, obstetric, and psychological differences were found between continuous smokers, quitters, and non-smokers. These data suggest that two-bytwo smoking status group comparisons (e.g. smokers vs. non-smokers) performed in previous studies (e.g. Al-Sahab et al. 2010; Orr et al. 2012 ) may underrepresent the results. The group of women who did not smoke, formed by nonsmokers and quitters, is not an uniform group, and the variables associated with not smoking during pregnancy are not always the same as those associated with the cessation of consumption. For example, regarding parity, the group of non-smokers has the highest percentage of multiparous women (37.0%), while the group of quitters has the highest percentage of primiparous women (79.7%). Therefore, joining both groups could result that the differences in function of parity were minimized or even disappeared.
Regression analyses showed that to have a low level of studies, to have a smoking partner, and to present higher levels of anxiety symptoms at the first trimester of pregnancy and higher levels of depression symptoms at the third trimester are associated with continuous consumption during pregnancy. When only the first trimester was considered, results showed that higher levels of anxiety symptoms increased the probability of continued smoking during pregnancy. The greater importance of anxiety symptoms at the first trimester of pregnancy may be related to the fact that the early pregnancy period represents a time of great risks for pregnancy (Mook-Kanamori et al. 2010 ). Pregnant women not only have to adapt to their new situation, but also have to face concerns about the viability of pregnancy and/or the health of the foetus. The relationship between lower education and continuous tobacco consumption could be explained by not being fully aware of the harmful effects of tobacco use on the health of both the pregnant women and the unborn child (Driezen et al. 2016 ). In addition, living with other smokers is also associated with increased need to smoke due to a ''contagion effect'' and mean a greater availability of tobacco at home that is difficult for the women's control of stimulus (Doz et al. 2004) . The relationship between higher levels of anxiety symptoms at the first trimester and continuing smoking have been found in the literature (e.g. Goedhart et al. 2009 ) and could be explained by the presence of more stress according to the identified risk factors present in women who continued smoked during pregnancy (they were less likely to be married or partnered and to receive a higher monthly salary). Moreover, this relationship can also be sustained by the belief that smoking helps to relax and control negative emotions (Irwin et al. 2005) , becoming a coping strategy. However, our data do not support this belief, since no decrease in the levels of anxiety and depression across pregnancy was found in women who continued smoking during pregnancy, contrarily to what was observed in both non-smokers and quitters. Moreover, when both the first and the third trimesters were considered, a significant association was found between continuous tobacco consumption and depression symptoms at the third trimester. Although smoking can be used as a tool to cope with negative mood (Zhu and Valvo 2002) , our results suggested that continued smoking during pregnancy could increase depression symptoms.
Regarding the differences on women's depression and anxiety symptoms from the first to the third trimester of pregnancy according to smoking status, our data show that quitting is associated with a reduction in depression and anxiety symptoms, so there is an improvement in mental health, as noted by Taylor et al. (2014) . Thus, it can be observed that the levels of depression and anxiety symptoms of women who spontaneously quit smoking at the first trimester of pregnancy decrease to similar levels of women who do not smoke, as non-significant differences were found between both groups. Likewise, our data also seem to corroborate that smoking could increase mental health problems (Flensborg-Madsen et al. 2011; Minichino et al. 2013) . Continuous smokers maintain the highest levels of anxiety and depression symptoms throughout pregnancy, as significant differences were found with the group of non-smokers and quitters both at the first and at the third trimester of pregnancy.
One variable that stands out and which contribute should be better analysed in future studies on smoking during pregnancy and the post-partum period is breastfeeding intention and duration. In line with the literature, significant differences between the smoking status groups were found regarding breastfeeding intention, with smokers having the lower intentionality to breastfeed. Previous studies have related both depression symptoms and tobacco consumption status to breastfeeding. Specifically, higher levels of depression symptoms both during pregnancy (Figueiredo et al. 2014; Ystrom 2012) and during the postpartum (Ystrom 2012) were associated with breastfeeding no-intention, no-initiation, or early cessation. Likewise, continued smoking during pregnancy was related to breastfeeding no-initiation or a shorter duration (Giglia et al. 2007; Suzuki et al. 2010) . A relationship between quitting smoking in early pregnancy and the intention to breastfeed was found in the present study and has also been suggested in the literature. Women who intend to breastfeed are less likely to smoke and more likely to spontaneously quit smoking during pregnancy (Haslam et al. 2003; Joseph et al. 2017) . These data suggest the importance of promoting breastfeeding to improve smoking cessation and reduce depression symptoms, as well as the possible importance of improving smoking cessation and reducing depression symptoms to promote breastfeeding. Some limitations should be considered. Pre-pregnancy psychological assessments were not conducted, which does not allow to know how pregnancy affected the process of tobacco quitting due to anxiety and depression symptoms. In addition, depression and anxiety symptoms were assessed through self-reported measures.
Despite these limitations, this study has several strengths. Firstly, a large sample was used to study simultaneously relevant factors that previous research has found to be related to smoking during pregnancy. Secondly, this is a longitudinal study that assessed continued consumption and continued abstinence over pregnancy and performed comparisons between the three consumption groups (non-smokers, quitters, and continuous smokers). We consider that the variables associated with continuous abstinence or consumption are the most important variables to analyse because the objective should not be to achieve abstinence at a certain time of pregnancy, but the maintenance during all pregnancy. Moreover, the pregnant women's self-reports of smoking abstinence were biochemically validated to control for social desirability bias. This is particularly relevant during pregnancy when higher social pressure for women not smoking is present (Míguez and Pereira 2018) .
In conclusion, this study showed how levels of depression and anxiety are influenced both by the time of pregnancy evaluated and by the smoking status, with continuous smokers during pregnancy at risk of increasing anxiety and depression symptoms. The main clinical implications of our results concern the relevance of screening for anxiety and depression early in pregnancy to identify women at risk of smoking during the entire pregnancy. Also, this study reinforces the idea that future prenatal smoking cessation interventions must take into account these variables.
